ALE1
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ALE1, covering 2026-01-30 to 2026-01-30. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ALE1 in Healthy Adults and Adults With Hypophosphatasia in Order to Identify Suitable Doses of ALE1 [Phase 1, Phase 2]